Παντελεήμων Σαραφίδης

Πρωτεύουσες καρτέλες

Ο κατάλογος των δημοσιεύσεων είναι ενδεικτικός και μπορεί να μην περιλαμβάνει το σύνολο των δημοσιεύσεων.

2020
Alexandrou, M. Eleni, Loutradis C., Schoina M., Tzanis G., Dimitriadis C., Sachpekidis V., et al. (2020).  Ambulatory blood pressure profile and blood pressure variability in peritoneal dialysis compared with hemodialysis and chronic kidney disease patients.. Hypertens Res. 43(9), 903-913.
Theodorakopoulou, M., Loutradis C., Bikos A., Angeloudi E., Schoina M., Raptis V., et al. (2020).  The Effects of Nebivolol and Irbesartan on Ambulatory Aortic Blood Pressure and Arterial Stiffness in Hemodialysis Patients with Intradialytic Hypertension.. Blood Purif. 1-11.
Sampani, E., Sarafidis P., & Papagianni A. (2020).  Euglycaemic diabetic ketoacidosis as a complication of SGLT-2 inhibitors: epidemiology, pathophysiology, and treatment.. Expert Opin Drug Saf. 19(6), 673-682.
Loutradis, C., & Sarafidis P. (2020).  Pharmacotherapy of hypertension in patients with pre-dialysis chronic kidney disease.. Expert Opin Pharmacother. 21(10), 1201-1217.
Schoina, M., Loutradis C., Theodorakopoulou M., Dimitroulas T., Triantafillidou E., Doumas M., et al. (2020).  The presence of diabetes mellitus further impairs structural and functional capillary density in patients with chronic kidney disease.. Microcirculation. e12665.
Fernandez-Fernandez, B., D'Marco L., Gorriz J. Luis, Jacobs-Cachá C., Kanbay M., Luis-Lima S., et al. (2020).  Exploring Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors for Organ Protection in COVID-19.. J Clin Med. 9(7), 
Sarafidis, P., Faitatzidou D., & Papagianni A. (2020).  Benefits and risks of frequent or longer haemodialysis: weighing the evidence.. Nephrol Dial Transplant.
Fernandez-Fernandez, B., Sarafidis P., Kanbay M., Navarro-González J. F., Soler M. José, Gorriz J. Luis, et al. (2020).  SGLT2 inhibitors for non-diabetic kidney disease: drugs to treat CKD that also improve glycaemia.. Clin Kidney J. 13(5), 728-733.
Sarafidis, P., Loutradis C., Ferro C. J., & Ortiz A. (2020).  SGLT-2 Inhibitors to Treat Hyponatremia Associated with SIADH: A Novel Indication?. Am J Nephrol. 51(7), 553-555.
Sarafidis, P. A., & Ortiz A. (2020).  The risk for urinary tract infections with sodium-glucose cotransporter 2 inhibitors: no longer a cause of concern?. Clin Kidney J. 13(1), 24-26.
Loutradis, C., Schoina M., Dimitroulas T., Doumas M., Garyfallos A., Karagiannis A., et al. (2020).  Comparison of ambulatory central hemodynamics and arterial stiffness in patients with diabetic and non-diabetic CKD.. J Clin Hypertens (Greenwich).
Mallamaci, F., Torino C., Sarafidis P., Ekart R., Loutradis C., Siamopoulos K., et al. (2020).  Treatment-resistant hypertension in the hemodialysis population: a 44-h ambulatory blood pressure monitoring-based study.. J Hypertens. 38(9), 1849-1856.
Sarafidis, P. A., Loutradis C., Karpetas A., Tzanis G., Bikos A., Raptis V., et al. (2020).  The association of interdialytic blood pressure variability with cardiovascular events and all-cause mortality in haemodialysis patients.. Nephrol Dial Transplant. 35(7), 1277.
Sampani, E., Sarafidis P., Dimitriadis C., Kasimatis E., Daikidou D., Bantis K., et al. (2020).  Severe euglycemic diabetic ketoacidosis of multifactorial etiology in a type 2 diabetic patient treated with empagliflozin: case report and literature review.. BMC Nephrol. 21(1), 276.
Sarafidis, P., Ferro C. J., Morales E., Ortiz A., Malyszko J., Hojs R., et al. (2020).  Erratum.. Nephrol Dial Transplant. 35(8), 1452.
Sarafidis, P., & Bakris G. (2020).  Diastolic Blood Pressure Does Not Influence Cardiovascular Outcomes in Type 2 Diabetes; or Does It?. Diabetes Care. 43(8), 1684-1686.
Alexandrou, M-E., Loutradis C., Balafa O., Theodorakopoulou M., Tzanis G., Bakaloudi D., et al. (2020).  A comparative study of ambulatory central hemodynamics and arterial stiffness parameters in peritoneal dialysis and hemodialysis patients.. J Hypertens. 38(12), 2393-2403.
Sarafidis, P., Ferro C. J., Morales E., Ortiz A., Malyszko J., Hojs R., et al. (2020).  SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA.. Nephrol Dial Transplant. 35(10), 1825.
Sarafidis, P., Loutradis C., Ortiz A., & Ruilope L. M. (2020).  Blood pressure targets in patients with chronic kidney disease: MDRD and AASK now confirming SPRINT.. Clin Kidney J. 13(3), 287-290.
Alexandrou, M-E., Balafa O., & Sarafidis P. (2020).  Assessment of Hydration Status in Peritoneal Dialysis Patients: Validity, Prognostic Value, Strengths, and Limitations of Available Techniques.. Am J Nephrol. 51(8), 589-612.
Loutradis, C., Ferro C. J., & Sarafidis P. (2020).  Hypertension Management in Patients With Autosomal Dominant Polycystic Kidney Disease: Time for a Paradigm Shift?. Am J Kidney Dis. 76(5), 743.
2019
Alexandrou, M-E., Papagianni A., Tsapas A., Loutradis C., Boutou A., Piperidou A., et al. (2019).  Effects of mineralocorticoid receptor antagonists in proteinuric kidney disease: a systematic review and meta-analysis of randomized controlled trials.. J Hypertens. 37(12), 2307-2324.
Piperidou, A., Sarafidis P., Boutou A., Thomopoulos C., Loutradis C., Alexandrou M. Eleni, et al. (2019).  The effect of SGLT-2 inhibitors on albuminuria and proteinuria in diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.. J Hypertens. 37(7), 1334-1343.
Theodorakopoulou, M., Raptis V., Loutradis C., & Sarafidis P. (2019).  Hypoxia and Endothelial Dysfunction in Autosomal-Dominant Polycystic Kidney Disease.. Semin Nephrol. 39(6), 599-612.
Loutradis, C., Papadopoulou E., Theodorakopoulou M., Karagiannis A., & Sarafidis P. (2019).  The effect of SGLT-2 inhibitors on blood pressure: a pleiotropic action favoring cardio- and nephroprotection.. Future Med Chem. 11(11), 1285-1303.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές